|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| A61K 31/513 | (2006.01) | ||
| A61K 31/7072 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2746404 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12824342.5 |
| Date of filing the European patent application | 2012-08-15 | |
| (97) | Date of publication of the European application | 2014-06-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-06 |
| (46) | Date of publication of the claims translation | 2018-04-25 |
| (86) | Number | PCT/JP2012/070745 |
| Date | 2012-08-15 |
| (87) | Number | WO 2013/024865 |
| Date | 2013-02-21 |
| (30) | Number | Date | Country code |
| 2011177838 | 2011-08-16 | JP |
| (72) |
ITO, Masanobu, JP
OKABE, Hiroyuki, JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd.,
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444,
JP
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Priešvėžinis agentas ir terapinio poveikio prognozavimo būdas pacientams, sergantiems gaubtinės ir tiesiosios žarnos vėžiu su KRAS mutacija |
| ANTITUMOR AGENT AND THERAPEUTIC EFFECT PREDICTION METHOD FOR PATIENTS WITH KRAS-MUTATED COLORECTAL CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 14 | 289.00 EUR |
| 2026-08-15 |